丘脑底核脑深部电刺激术对帕金森病合并抑郁影响的研究进展

doi:10.3969/j.issn.1674-8115.2021.06.019

摘要/Abstract

摘要：

抑郁是帕金森病（Parkinson's disease，PD）常见的非运动症状，是PD患者生活质量下降的重要因素。丘脑底核脑深部电刺激（subthalamic nucleus deep brain stimulation，STN-DBS）对PD运动症状疗效明确，而对PD患者抑郁情绪的影响尚无定论。该文从PD合并抑郁的流行病学特征及发病机制、STN-DBS对PD合并抑郁的影响机制、STN-DBS对PD合并抑郁影响的影像学及电生理研究、DBS术后药物调整对PD合并抑郁的影响，以及电极位置对PD患者情绪的影响等方面作一综述。

关键词: 帕金森病, 抑郁, 丘脑底核, 脑深部电刺激术

Abstract:

Depression is a common non-motor symptom of Parkinson′s disease (PD) and is a critical factor in the reduction of life quality of PD patients. The therapeutic effect of subthalamic nucleus deep brain stimulation (STN-DBS) on PD motor symptoms has been well documented. However, their effect on the related depression in PD is inconclusive. This article reviews the epidemiological characteristics and pathogenesis of PD and its related depression, the mechanism underlying the effects of STN-DBS on PD-related depression, the imaging and electrophysiological research of STN-DBS on PD and its related depression, the effects of STN-DBS on drug use, and the effects of electrode position on emotion.

Key words: Parkinson′s disease (PD), depression, subthalamic nucleus, deep brain stimulation

中图分类号:

R742.5

张小小, 张陈诚, 赖伊杰, 孙伯民. 丘脑底核脑深部电刺激术对帕金森病合并抑郁影响的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(6): 815-820.

Xiao-xiao ZHANG, Chen-cheng ZHANG, Yi-jie LAI, Bo-min SUN. Recent progresses in deep brain stimulation of subthalamic nucleus on Parkinson′s disease and its related depression[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 815-820.

参考文献 64

1	Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review[J]. JAMA, 2020, 323(6): 548-560.
2	Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial[J]. Am J Psychiatry, 2011, 168(10): 1066-1074.
3	Luquin MR, Kulisevsky J, Martinez-Martin P, et al. Consensus on the definition of advanced Parkinson's disease: a neurologists-based Delphi study (CEPA study)[J]. Parkinsons Dis, 2017, 2017: 4047392.
4	Kuhlman GD, Flanigan JL, Sperling SA, et al. Predictors of health-related quality of life in Parkinson's disease[J]. Park Relat Disord, 2019, 65: 86-90.
5	Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes[J]. Mov Disord, 2006, 21(): S290-S304.
6	Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease: a meta-analysis[J]. Neuropsychol Rev, 2015, 25(4): 439-454.
7	Abbes M, Lhommée E, Thobois S, et al. Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study[J]. J Neurol Neurosurg Psychiatry, 2018, 89(8): 836-843.
8	Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours[J]. Brain, 2012, 135(Pt 5): 1463-1477.
9	Lilleeng B, Gjerstad M, Baardsen R, et al. The long-term development of non-motor problems after STN-DBS[J]. Acta Neurol Scand, 2015, 132(4): 251-258.
10	Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease[J]. Mov Disord, 2008, 23(2): 183-189;quiz313.
11	Chagas MH, Moriyama TS, Felício AC, et al. Depression increases in patients with Parkinson's disease according to the increasing severity of the cognitive impairment[J]. Arq Neuropsiquiatr, 2014, 72(6): 426-429.
12	Shen CC, Tsai SJ, Perng CL, et al. Risk of Parkinson disease after depression: a nationwide population-based study[J]. Neurology, 2013, 81(17): 1538-1544.
13	Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint[J]. Adv Neurol, 1995, 65: 49-60.
14	Ossowska K, Lorenc-Koci E. Depression in Parkinson's disease[J]. Pharmacol Rep, 2013, 65(6): 1545-1557.
15	Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease[J]. Arch Gen Psychiatry, 2007, 64(12): 1385-1392.
16	Wang JY, Fan QY, He JH, et al. SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson's disease: an exploratory study[J]. Front Neurol, 2019, 10: 333.
17	Meloni M, Puligheddu M, Carta M, et al. Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding[J]. Eur J Neurol, 2020, 27(5): 779-786.
18	Braak H, Ghebremedhin E, Rüb U, et al. Stages in the development of Parkinson's disease-related pathology[J]. Cell Tissue Res, 2004, 318(1): 121-134.
19	Kostić VS, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease[J]. Neurology, 2010, 75(10): 857-863.
20	Aarsland D, Påhlhagen S, Ballard CG, et al. Depression in Parkinson disease: epidemiology, mechanisms and management[J]. Nat Rev Neurol, 2011, 8(1): 35-47.
21	Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial[J]. Lancet Neurol, 2013, 12(1): 37-44.
22	Zhou HY, Wang LB, Zhang CC, et al. Acute effects of subthalamic deep brain stimulation on motor outcomes in Parkinson's disease; 13 year follow up[J]. Front Neurol, 2019, 10: 689.
23	Chopra A, Abulseoud OA, Sampson S, et al. Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study[J]. Psychosomatics, 2014, 55(5): 478-484.
24	Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004, 75(6): 834-839.
25	McDonald LM, Page D, Wilkinson L, et al. Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease[J]. Mov Disord, 2012, 27(3): 372-378.
26	Fabbri M, Coelho M, Guedes LC, et al. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 41: 113-117.
27	Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation[J]. N Engl J Med, 1999, 340(19): 1476-1480.
28	Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease[J]. Mov Disord, 2002, 17(5): 1084-1085.
29	Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial[J]. Ann Neurol, 2009, 65(5): 586-595.
30	Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease[J]. N Engl J Med, 2010, 362(22): 2077-2091.
31	Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients[J]. Neurology, 2002, 59(9): 1427-1429.
32	Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation[J]. J Neurol Neurosurg Psychiatry, 2002, 72(6): 701-707.
33	Strutt AM, Simpson R, Jankovic J, et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease[J]. Eur J Neurol, 2012, 19(1): 121-127.
34	Petersson P, Halje P, Cenci MA. Significance and translational value of high-frequency cortico-basal Ganglia oscillations in Parkinson's disease[J]. J Parkinsons Dis, 2019, 9(1): 183-196.
35	Karachi C, Yelnik J, Tandé D, et al. The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in Primates[J]. Mov Disord, 2005, 20(2): 172-180.
36	Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease[J]. J Cereb Blood Flow Metab, 2004, 24(1): 7-16.
37	Temel Y, Blokland A, Steinbusch HW, et al. The functional role of the subthalamic nucleus in cognitive and limbic circuits[J]. Prog Neurobiol, 2005, 76(6): 393-413.
38	Rodriguez-Oroz MC, Gorospe A, Guridi J, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease[J]. Neurology, 2000, 55(12 ): S45-S51.
39	Kim HJ, Jeon BS, Paek SH. Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson's disease[J]. J Mov Disord, 2015, 8(2): 83-91.
40	Politis M, Wu K, Loane C, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study[J]. Neurobiol Dis, 2010, 40(1): 216-221.
41	Tan SK, Hartung H, Sharp T, et al. Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?[J]. Neuropharmacology, 2011, 61(3): 387-399.
42	Navailles S, Benazzouz A, Bioulac B, et al. High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and Hippocampus in a rat model of Parkinson's disease[J]. J Neurosci, 2010, 30(6): 2356-2364.
43	Stefani A, Cerroni R, Mazzone P, et al. Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity[J]. Eur J Neurosci, 2019, 49(6): 805-816.
44	Kumar R, Lozano AM, Sime E, et al. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation[J]. Neurology, 1999, 53(3): 561-566.
45	Cummings JL. Frontal-subcortical circuits and human behavior[J]. Arch Neurol, 1993, 50(8): 873-880.
46	Klauser P, Fornito A, Lorenzetti V, et al. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder[J]. J Affect Disord, 2015, 173: 45-52.
47	Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study[J]. Mov Disord, 2008, 23(1): 42-46.
48	Cardoso EF, Maia FM, Fregni F, et al. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus[J]. Neuroimage, 2009, 47(2): 467-472.
49	Jeune F, Péron J, Grandjean D, et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study[J]. Eur J Nucl Med Mol Imaging, 2010, 37(8): 1512-1520.
50	Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease[J]. Neurology, 2009, 72(1): 42-49.
51	Langner-Lemercier S, Drapier S, Naudet F, et al. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease[J]. J Neurol, 2015, 262(4): 881-889.
52	Rappel P, Grosberg S, Arkadir D, et al. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus[J]. Mov Disord, 2020, 35(2): 337-343.
53	Kühn AA, Hariz MI, Silberstein P, et al. Activation of the subthalamic region during emotional processing in Parkinson disease[J]. Neurology, 2005, 65(5): 707-713.
54	Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation[J]. Brain, 2010, 133(Pt 4): 1111-1127.
55	Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease[J]. Brain, 2008, 131(Pt 10): 2720-2728.
56	Alexoudi A, Shalash A, Knudsen K, et al. The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation[J]. Parkinsonism Relat Disord, 2015, 21(6): 555-560.
57	Zibetti M, Cinquepalmi A, Angrisano S, et al. Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2009, 15(): S76-S80.
58	Yu XX, Fernandez HH. Dopamine agonist withdrawal syndrome: a comprehensive review[J]. J Neurol Sci, 2017, 374: 53-55.
59	Brunenberg EJ, Moeskops P, Backes WH, et al. Structural and resting state functional connectivity of the subthalamic nucleus: identification of motor STN parts and the hyperdirect pathway[J]. PLoS One, 2012, 7(6): e39061.
60	Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, et al. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts[J]. Brain Stimul, 2018, 11(4): 904-912.
61	Krack P, Hariz MI, Baunez C, et al. Deep brain stimulation: from neurology to psychiatry?[J]. Trends Neurosci, 2010, 33(10): 474-484.
62	Blomstedt P, Hariz MI, Lees A, et al. Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report[J]. Parkinsonism Relat Disord, 2008, 14(3): 253-256.
63	Starkstein SE, Brockman S. Management of depression in Parkinson's disease: a systematic review[J]. Mov Disord Clin Pract, 2017, 4(4): 470-477.
64	苗海锋, 马荣, 吴志强, 等. 帕罗西汀治疗帕金森病伴发抑郁障碍临床疗效与安全性分析[J]. 中国实用神经疾病杂志, 2014, 17(4): 9-12.

[1]	周亦凝, 叶之韵, 陈慧文, 谢欣宜, 周薇, 宋忠臣. Th17细胞特异性敲除Stat3对牙周炎小鼠焦虑抑郁样行为的影响[J]. 上海交通大学学报（医学版）, 2025, 45(7): 838-845.
[2]	曹明明, 王辉, 尹雅芙. 帕金森病认知功能障碍影像标志物的研究现状[J]. 上海交通大学学报（医学版）, 2025, 45(5): 646-652.
[3]	王思睿, 孔盖, 李惠, 钱禛颖, 崔慧茹, 唐莺莹. 经颅磁刺激治疗对抑郁症患者杏仁核及海马亚区体积的影响[J]. 上海交通大学学报（医学版）, 2025, 45(4): 434-442.
[4]	耿梦璐, 李春波. 抑郁障碍患者记忆提取抑制受损的研究进展[J]. 上海交通大学学报（医学版）, 2025, 45(10): 1378-1382.
[5]	赵欣欣, 裴孟超. 纹理多参数分析在帕金森病患者脑磁化率定量中的应用研究[J]. 上海交通大学学报（医学版）, 2025, 45(1): 69-78.
[6]	陈深册, 陈依明, 王凡, 张梦珂, 杨惟杰, 吕洞宾, 洪武. 饮食干预治疗抑郁相关症状的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(8): 1050-1055.
[7]	苏珊珊, 蒋文晖, 王书婷, 徐觅真, 任雪晴, 仇剑崟. 焦虑障碍患者的焦虑水平、述情障碍程度对其生活质量的影响[J]. 上海交通大学学报（医学版）, 2024, 44(5): 584-590.
[8]	孙晨寅, 吴百川, 张慧凤, 方贻儒, 彭代辉. 体动记录仪评估抑郁症昼夜节律：一项系统综述和meta分析[J]. 上海交通大学学报（医学版）, 2024, 44(5): 606-616.
[9]	谷涓华, 焦扬, 鲁琳, 王琳琳. 胶质细胞内SNARE复合体功能及其与抑郁障碍发生的关系[J]. 上海交通大学学报（医学版）, 2024, 44(5): 653-657.
[10]	杨瑞君, 吕书红, 刘志业, 张新, 刘志浩. 中国5省初中生视屏时间和饮食行为与抑郁症状的关联[J]. 上海交通大学学报（医学版）, 2024, 44(3): 358-364.
[11]	胡灿芳, 钟传钰, 曹立. 神经调控技术在帕金森病治疗中的应用研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(2): 258-263.
[12]	卢启帆, 刘启明, 周红梅, 柴烨子, 姜萌, 卜军. 慢性心力衰竭患者躯体化症状、焦虑、抑郁对临床结局的影响[J]. 上海交通大学学报（医学版）, 2023, 43(9): 1153-1161.
[13]	马文琳, 林元杰, 金婷婷, 石薇, 蒋莉华, 赵莉. 初中生自我中心主义与非自杀性自伤的关系研究[J]. 上海交通大学学报（医学版）, 2023, 43(8): 971-976.
[14]	张硕渊, 李春波. 运动治疗抑郁障碍的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(7): 916-922.
[15]	马翠, 叶钰娟, 严兴科. 杏仁核介导的痛情绪神经环路研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(10): 1304-1310.